CERAGON NETWORKS LTD.
(Translation of registrant’s name into English)
|
24 Raoul Wallenberg Street, Tel Aviv 69719, Israel
(Address of principal executive offices)
|
CERAGON NETWORKS LTD.
|
|||
Date: February 13, 2014
|
By: |
/s/ Donna Gershowitz
|
|
Name:
Title:
|
Donna Gershowitz
VP and General Counsel
|
Exhibit Description
Exhibit A – CERAGON NETWORKS REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS
|
Geographical breakdown, fourth quarter of 2013:
|
||
·
|
Europe:
|
20%
|
·
|
Africa:
|
11%
|
·
|
North America:
|
10%
|
·
|
Latin America:
|
40%
|
·
|
India:
|
8%
|
·
|
APAC:
|
11%
|
Geographical breakdown, full year 2013:
|
||
·
|
Europe:
|
18%
|
·
|
Africa:
|
20%
|
·
|
North America:
|
9%
|
·
|
Latin America:
|
34%
|
·
|
India:
|
8%
|
·
|
APAC:
|
11%
|
Investors:
|
||
Aviram Steinhart
|
or
|
Claudia Gatlin
|
+972 3 5431 443
|
+1 201 853 0228
|
|
avirams@ceragon.com
|
claudiag@ceragon.com
|
|
Media:
|
||
Yoel Knoll
|
||
+972 3 5431 32 or
|
||
+1 201 853 0271
|
||
yoelk@ceragon.com
|
Three months ended
December 31
|
Year ended
December 31,
|
|||||||||||||||
2013
|
2012
|
2013
|
2012
|
|||||||||||||
Revenues
|
$ | 89,492 | $ | 106,849 | $ | 361,772 | $ | 446,651 | ||||||||
Cost of revenues
|
61,751 | 71,802 | 249,543 | 308,354 | ||||||||||||
Gross profit
|
27,741 | 35,047 | 112,229 | 138,297 | ||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development, net
|
10,409 | 12,007 | 42,962 | 47,487 | ||||||||||||
Selling and marketing
|
17,106 | 18,564 | 67,743 | 77,326 | ||||||||||||
General and administrative
|
8,089
|
6,925
|
26,757
|
27,519
|
||||||||||||
Restructuring costs
|
9,345
|
4,608
|
9,345
|
4,608
|
||||||||||||
Other income
|
(7,657 | ) | - | (7,657 | ) | - | ||||||||||
Total operating expenses
|
$ | 37,292 | $ | 42,104 | $ | 139,150 | $ | 156,940 | ||||||||
Operating loss
|
9,551 | 7,058 | 26,921 | 18,643 | ||||||||||||
Financial expenses, net
|
5,162 | 938 | 14,018 | 3,547 | ||||||||||||
Loss before taxes
|
14,713 | 7,995 | 40,939 | 22,190 | ||||||||||||
Taxes on income
|
664 | 405 | 6,539 | 1,201 | ||||||||||||
Net loss
|
$ | 15,377 | $ | 8,400 | $ | 47,478 | $ | 23,391 | ||||||||
Basic and diluted net loss per share
|
$ | 0.35 | $ | 0.23 | $ | 1.23 | $ | 0.64 | ||||||||
Weighted average number of shares used in computing basic and diluted net loss per share
|
43,639,777 | 36,565,168 | 38,519,606 | 36,457,989 |
(Unaudited)
|
December 31,
2013
|
December 31,
2012
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$ | 42,407 | $ | 47,099 | ||||
Short-term bank deposits
|
446 | 422 | ||||||
Marketable securities
|
5,499 | - | ||||||
Trade receivables, net
|
131,166 | 149,120 | ||||||
Deferred taxes, net
|
7,198 | 8,589 | ||||||
Other accounts receivable and prepaid expenses
|
34,205 | 38,743 | ||||||
Inventories
|
64,239 | 65,554 | ||||||
Total current assets
|
285,160 | 309,527 | ||||||
NON-CURRENT ASSETS:
|
||||||||
Marketable securities
|
3,985 | 4,068 | ||||||
Deferred tax assets, net
|
6,542 | 9,140 | ||||||
Severance pay and pension funds
|
7,065 | 7,163 | ||||||
Property and equipment, net
|
35,245 | 33,642 | ||||||
Intangible assets, net
|
7,213 | 9,809 | ||||||
Goodwill
|
14,935 | 15,283 | ||||||
Other non-current assets
|
5,826 | 4,964 | ||||||
80,811 | 84,069 | |||||||
Total assets
|
$ | 365,971 | $ | 393,596 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Short term loan, including current maturities of long term bank loan
|
$ | 46,922 | $ | 25,232 | ||||
Trade payables
|
77,979 | 102,079 | ||||||
Deferred revenues
|
7,968 | 16,719 | ||||||
Other accounts payable and accrued expenses
|
45,526 | 36,090 | ||||||
Total current liabilities
|
178,395 | 180,120 | ||||||
LONG-TERM LIABILITIES
|
||||||||
Long term bank loan, net of current maturities
|
10,304 | 18,536 | ||||||
Accrued severance pay and pension
|
13,635 | 12,311 | ||||||
Other long term payables
|
28,559 | 38,920 | ||||||
52,498 | 69,767 | |||||||
SHAREHOLDERS' EQUITY:
|
||||||||
Share capital:
|
||||||||
Ordinary shares
|
141 | 98 | ||||||
Additional paid-in capital
|
357,989 | 318,106 | ||||||
Treasury shares at cost
|
(20,091 | ) | (20,091 | ) | ||||
Other comprehensive loss
|
(1,569 | ) | (490 | ) | ||||
Accumulated deficits
|
(201,392 | ) | (153,914 | ) | ||||
Total shareholders' equity
|
135,078 | 143,709 | ||||||
Total liabilities and shareholders' equity
|
$ | 365,971 | $ | 393,596 |
Three months ended
December 31,
|
Year ended
December 31,
|
|||||||||||||||
2013
|
2012
|
2013
|
2012
|
|||||||||||||
Cash flow from operating activities:
|
||||||||||||||||
Net loss
|
$ | (15,377 | ) | $ | (8,400 | ) | $ | (47,478 | ) | $ | (23,391 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||||||
Depreciation and amortization
|
3,989 | 3,802 | 15,645 | 15,030 | ||||||||||||
Stock-based compensation expense
|
1,048 | 1,215 | 3,822 | 5,460 | ||||||||||||
Write off of property and equipment
|
2,559 | - | 2,559 | - | ||||||||||||
Capital loss from marketable securities
|
2,108 | - | 2,108 | - | ||||||||||||
Decrease (Increase) in trade and other receivables, net
|
(2,062 | ) | 27,768 | 18,272 | (11,753 | ) | ||||||||||
Decrease (Increase) in inventory, net of write off
|
(7,092 | ) | (1,599 | ) | 401 | 27,210 | ||||||||||
Increase (decrease) in trade payables and accrued liabilities
|
(1,975 | ) | 274 | (21,044 | ) | 17,712 | ||||||||||
Decrease in deferred revenues
|
(533 | ) | (5,170 | ) | (8,751 | ) | (21,589 | ) | ||||||||
Decrease (increase) in deferred tax asset, net
|
(171 | ) | (324 | ) | 3,572 | (743 | ) | |||||||||
Other adjustments
|
1,404 | (481 | ) | 1,382 | (727 | ) | ||||||||||
Net cash provided by (used in) operating activities
|
$ | (16,102 | ) | $ | 17,085 | $ | (29,512 | ) | $ | 7,209 | ||||||
Cash flow from investing activities:
|
||||||||||||||||
Purchase of property and equipment ,net
|
(4,717 | ) | (4,317 | ) | (16,423 | ) | (14,530 | ) | ||||||||
Investment in short and long-term bank deposit
|
(424 | ) | - | (679 | ) | (1,266 | ) | |||||||||
Proceeds from maturities of short and long-term bank deposits
|
299 | - | 635 | 7,920 | ||||||||||||
Investment in available for sale marketable securities
|
(7,867 | ) | - | (7,867 | ) | (64 | ) | |||||||||
Proceeds from sales of available for sale marketable securities
|
212 | - | 513 | 9,781 | ||||||||||||
Net cash provided by (used in) investing activities
|
$ | (12,497 | ) | $ | (4,317 | ) | $ | (23,821 | ) | $ | 1,841 | |||||
Cash flow from financing activities:
|
||||||||||||||||
Proceeds from exercise of options
|
- | 2 | 1,145 | 736 | ||||||||||||
Proceeds from issuance of shares, net
|
34,957 | - | 34,957 | - | ||||||||||||
Proceeds from financial institutions, net
|
(2,300 | ) | 2,000 | 23,690 | 27,000 | |||||||||||
Repayments of bank loans
|
(2,058 | ) | (12,058 | ) | (10,232 | ) | (18,232 | ) | ||||||||
Net cash provided by (used in) financing activities
|
$ | 30,599 | $ | (10,056 | ) | $ | 49,560 | $ | 9,504 | |||||||
Translation adjustments on cash and cash equivalents
|
$ | (175 | ) | $ | 36 | $ | (919 | ) | $ | (446 | ) | |||||
Increase (Decrease) in cash and cash equivalents
|
$ | 1,825 | $ | 2,748 | $ | (4,692 | ) | $ | 18,108 | |||||||
Cash and cash equivalents at the beginning of the period
|
40,582 | 44,351 | 47,099 | 28,991 | ||||||||||||
Cash and cash equivalents at the end of the period
|
$ | 42,407 | $ | 47,099 | $ | 42,407 | $ | 47,099 |
Three months ended December 31,
|
||||||||||||||||
2013
|
2012
|
|||||||||||||||
GAAP (as reported)
|
Adjustments
|
Non-GAAP
|
Non-GAAP
|
|||||||||||||
Revenues
|
$ | 89,492 | $ | 89,492 | $ | 106,849 | ||||||||||
Cost of revenues
|
61,751 |
(a) 990
|
60,761 | 71,307 | ||||||||||||
Gross profit
|
27,741 | 28,731 | 35,542 | |||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development, net
|
10,409 |
(b) 1,822
|
8,587 | 10,539 | ||||||||||||
Selling and marketing
|
17,106 |
(c) 1,219
|
15,887 | 17,344 | ||||||||||||
General and administrative
|
8,089 |
(d) 2,252
|
5,837 | 5,895 | ||||||||||||
Restructuring costs
|
9,345 | 9,345 | - | - | ||||||||||||
Other income
|
(7,657 | ) |
(e) (7,657
|
) | - | - | ||||||||||
Total operating expenses
|
$ | 37,292 | $ | 30,311 | $ | 33,778 | ||||||||||
Operating profit (loss)
|
(9,551 | ) | (1,580 | ) | 1,764 | |||||||||||
Financial expenses, net
|
5,162 |
(f) 3,320
|
1,842 | 938 | ||||||||||||
Income (loss) before taxes
|
(14,713 | ) | (3,422 | ) | 826 | |||||||||||
Taxes on income
|
664 | 664 | 405 | |||||||||||||
Net income (loss)
|
$ | (15,377 | ) | $ | (4,086 | ) | $ | 421 | ||||||||
Basic net earnings (loss) per share
|
$ | (0.35 | ) | $ | (0.09 | ) | $ | 0.01 | ||||||||
Diluted net earnings (loss) per share
|
$ | (0.35 | ) | $ | (0.09 | ) | $ | 0.01 | ||||||||
Weighted average number of shares used in computing basic net earnings (loss) per share
|
43,639,777 | 43,639,777 | 36,565,168 | |||||||||||||
Weighted average number of shares used in computing diluted net earnings (loss) per share
|
43,639,777 | 43,639,777 | 36,641,920 | |||||||||||||
Total adjustments
|
11,291 |
(a)
|
Cost of revenues includes $0.3 million of amortization of intangible assets, $40 thousand of stock based compensation expenses, $0.2 million of changes in pre-acquisition indirect tax positions and $0.4 million of the Q4 2013 restructuring plan related costs in the three months ended December 31, 2013.
|
(b)
|
Research and development expenses include $1.6 million of the Q4 2013 restructuring related costs and $0.3 million of stock based compensation expenses in the three months ended December 31, 2013.
|
(c)
|
Selling and marketing expenses includes $0.3 million of amortization of intangible assets, $0.6 million of the Q4 2013 restructuring related costs and $0.2 million of stock based compensation expenses in the three months ended December 31, 2013.
|
(d)
|
General and administrative expenses include $0.6 million of the Q4 2013 restructuring related costs, $1.3 million of non-recurring adjustment of pension liabilities in Norway as a result of a change in the official Norwegian data regarding estimated life expectancy and $0.4 million of stock based compensation expenses in the three months ended December 31, 2013.
|
(e)
|
Other income includes $7.7 million related to the expiration of certain pre-acquisition indirect tax exposures during the three months ended December 31, 2013.
|
(f)
|
Financial expenses include $3.3 million related to actions taken in order to expatriate cash from Argentina in the three months ended December 31, 2013.
|
Year ended December 31,
|
||||||||||||||||
2013
|
2012
|
|||||||||||||||
GAAP (as reported)
|
Adjustments
|
Non-GAAP
|
Non-GAAP
|
|||||||||||||
Revenues
|
$ | 361,772 | $ | 361,772 | $ | 446,651 | ||||||||||
Cost of revenues
|
249,543 |
(a) 3,792
|
245,751 | 299,781 | ||||||||||||
Gross profit
|
112,229 | 116,021 | 146,870 | |||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development, net
|
42,962 |
(b) 3,810
|
39,152 | 44,584 | ||||||||||||
Selling and marketing
|
67,743 |
(c) 3,957
|
63,786 | 72,306 | ||||||||||||
General and administrative
|
26,757 |
(d) 3,768
|
22,989 | 25,167 | ||||||||||||
Restructuring costs
|
9,345 | 9,345 | - | - | ||||||||||||
Other income
|
(7,657 | ) |
(e) (7,657
|
) | - | - | ||||||||||
Total operating expenses
|
$ | 139,150 | $ | 125,927 | $ | 142,057 | ||||||||||
Operating profit (loss)
|
(26,921 | ) | (9,906 | ) | 4,813 | |||||||||||
Financial expenses, net
|
14,018 |
(f) 6,453
|
7,565 | 3,547 | ||||||||||||
Income (loss) before taxes
|
(40,939 | ) | (17,471 | ) | 1,266 | |||||||||||
Taxes on income
|
6,539 |
(g) 4,037
|
2,502 | 1,201 | ||||||||||||
Net income (loss)
|
$ | (47,478 | ) | $ | (19,973 | ) | $ | 65 | ||||||||
Basic net earnings (loss) per share
|
$ | (1.23 | ) | $ | (0.52 | ) | $ | 0.00 | ||||||||
Diluted net earnings (loss) per share
|
$ | (1.23 | ) | $ | (0.52 | ) | $ | 0.00 | ||||||||
Weighted average number of shares used in computing basic net earnings (loss) per share
|
38,519,606 | 38,519,606 | 36,457,989 | |||||||||||||
Weighted average number of shares used in computing diluted net earnings (loss) per share
|
38,519,606 | 38,519,606 | 37,092,887 | |||||||||||||
Total adjustments
|
27,505 |
(a)
|
Cost of revenues includes $1.2 million of amortization of intangible assets, $0.5 million of inventory step-up, $1.3 million of changes in pre-acquisition indirect tax positions, $0.2 million of stock based compensation expenses and $0.7 million of the Q4 2013 restructuring related costs in the year ended December 31, 2013.
|
(b)
|
Research and development expenses include $2.8 million of the Q4 2013 restructuring related costs and $1.0 million of stock based compensation expenses in the year ended December 31, 2013.
|
(c)
|
Selling and marketing expenses includes $1.3 million of amortization of intangible assets, $1.3 million of the Q4 2013 restructuring related costs and $1.3 million of stock based compensation expenses in the year ended December 31, 2013.
|
(d)
|
General and administrative expenses include $1.3 million of the Q4 2013 restructuring related costs, $1.3 million of non-recurring adjustment of pension liabilities in Norway as a result of a change in the official Norwegian data regarding estimated life expectancy and $1.2 million of stock based compensation expenses, in the year ended December 31, 2013.
|
(e)
|
Other income includes $7.7 million related to the expiration of certain pre-acquisition indirect tax exposures during the year ended December 31, 2013.
|
(f)
|
Financial expenses include $3.1 million non-recurring currency devaluation in Venezuela and $3.3 million charge related to actions taken in order to expatriate cash from Argentina in the year ended December 31, 2013.
|
(g)
|
Taxes on income include $4.0 million non-recurring adjustment of valuation allowance on tax assets in the year ended December 31, 2013.
|
Three months ended
|
Year ended
|
|||||||
December 31, 2013
|
||||||||
Reported GAAP net operating loss
|
(9,551 | ) | (26,921 | ) | ||||
Stock based compensation expenses
|
932 | 3,706 | ||||||
Amortization of purchased intangible assets
|
632 | 2,534 | ||||||
Inventory step up
|
- | 459 | ||||||
Restructuring expenses
|
9,345 | 9,345 | ||||||
Q4 2013 restructuring related costs
|
3,232 | 6,076 | ||||||
Expiration of certain pre-acquisition indirect tax exposures, net of interest accretion
|
(7,461 | ) | (6,396 | ) | ||||
Non-recurring adjustment of pension liabilities
|
1,291 | 1,291 | ||||||
Non-GAAP net operating loss
|
(1,580 | ) | (9,906 | ) |